The service can be used for seeking guidance on issues ranging from status of companies and matters pertaining to other regulators that are not under SEBI’s purview, to lodging complaints and getting information on opening demat and client accounts
Mumbai: Market regulator Securities and Exchange Board of India (SEBI) has launched a toll-free helpline for investors to provide guidance and assistance on various matters such as lodging complaints and transferring shares, reports PTI.
The number—1800227575—will be available to investors from all over India in 14 languages, SEBI said in a notification on Monday.
The service can be used for seeking guidance on issues ranging from status of companies and matters pertaining to other regulators that are not under SEBI’s purview, to lodging complaints and getting information on opening demat and client accounts.
Investors can also seek assistance on different procedures like transfer and transmission of shares and initial public offerings (IPOs).
Initially, the service will be available in English, Hindi, Marathi, Gujarati, Tamil, Bengali, Malayalam, Telugu, Urdu, Oriya and Punjabi.
The service in Kannada, Assamese and Kashmiri will commence shortly, SEBI said.
The toll free helpline service will be available on all working days from Monday to Friday between 9:30am and 5:30pm.
The conventional Ayurvedic doctor should have a reasonably good knowledge of the modern medical methods to be able to give proper advice to patients. A judicious combination of modern medicine and Ayurveda would be an ideal training for a family doctor
Ayurveda, the science of life, (Ayu=life; vid=science) is a part of the ageless Vedic heritage of India. Speculations about its origin go back thousands of years before Christ. Extensive literature on this subject, dating back to the fourth century BC has one thing in common that the essence of Ayurveda is to preserve good health, which is every human being’s birthright. Ayurveda prescribes lifestyle changes with emphasis on tranquillity of mind that is filled with universal compassion, as an insurance against an occasional illness. In this system disease is only an accident. Just as road accidents are rare if one follows traffic rules, disease would an exception if one follows the lifestyle prescribed in Ayurveda, which is not hard to comply with.
The human body has an inbuilt powerful immune system that could correct most, if not all, ills that man is heir to. In the unlikely event of this mechanism failing, and only then, should doctors interfere to help the system, whenever possible. In fact, the concept of immune deficiency syndromes had been prevalent there. Immune boosting methods are the mainstay of Ayurvedic therapeutics, the panchakarmas, and the five modalities.
Swasthasya swastha rakshitham
(Keep the well healthy as long as possible is the motto)
This motto would be a great help to modern medicine where a stage has come, what with the array of scopes and scanners, coupled with our inability to define normality precisely, we end up with having no normal healthy human beings at all. Among the many methods of preserving health in Ayurveda, the one that stands out is Sage Patanjali’s Yoga Shashtra, the science of Yoga. Unlike what is sold by the new age gurus, original Yoga had eight wings: rules for day-to-day living including diet, the art and ethics of living, regular exercise menu, the all important breathing method—pranayaama, detached outlook towards life, yogic postures for constant ease to enable one to practice the next steps of dhyaana—concentration, tranquillity of mind, and the ultimate realisation of the impermanence of life to make man fearless even in the face of death. Thus defined, Yoga becomes a way of life and not just a few contortions of the body for an hour or so daily. Yoga, in its true form, is a way of life.
Another distinct philosophy in Ayurveda is that every disease begins in our thoughts (consciousness) and grows in the body. Genetic contributions are very clearly understood, in addition. The concept is holistic and never reductionist. Man is a part of the universal consciousness, the environment and even the stars are supposed to have a role to play. Modern medicine is just trying to grapple with the role played by the mind in serious illnesses.1 Science, especially quantum physics, seems to be going into the new realm of human consciousness. Werner Heisenberg’s Uncertainty principle and Ervin Schrodinger’s Cat Hypothesis point in that direction. Recent studies of patients revived after cardiac arrest and those undergoing brain surgeries have pointed to the possibility of human consciousness (mind) outwit the brain in every single human cell.2, 3, 4 This all-pervasive consciousness has been the hallmark of Ayurvedic thinking.
Effectiveness of Ayurveda:
In the absence of its recognition by mainline science journals, the studies in the field of Ayurveda find it very difficult to get published, but there have been modern scientific enquiries into the effects of Yogic breathing.5 Millions all over the world now practice breathing methods for good health. It has become another big business with all market force trappings. Smallpox, the only scourge that we have been able to eradicate so far, was eradicated with the help of vaccination. The authentication for Edward Jenner’s anecdotal experience came from the prospective controlled study observations of a London physician, TZ Holwell, FRCP, FRS, who after studying Indian vaccination systems prospectively for twenty long years in The Bengal province of the Raj, reported his findings to the president and fellows of the London College in 1747. He wrote that the antiquity and the authenticity (90% protection of the vaccinated) could certainly give credibility to Jenner’s method. The graphic descriptions of the Indian method and its efficacy are portrayed in his paper, which could be viewed in the archives of the college library even today. Although slightly damaged by the great London fire of the 18th century, the document, providentially, survived the fire to show the original method that eventually led to the eradication of the greatest scourge of mankind.6 Recent evidence also suggests that the mind could initiate the cardiac rhythm and also the arrhythmias.7
Personality Types in Ayurveda:
Ayurveda classifies human beings into three distinct types, vaata, pitta, and kapha with multiple subtypes. This typing takes into account the pheno-typical and geno-typical features, in addition to consciousness. In short, it is a holistic concept, unlike the modern medical method of matching groups for controlled studies based on tiny fractions of the phenotype, like height, weight, age, sex and body mass index with a few of the biochemical and physical characteristics. This kind of science of reductionism has led to doctors predicting the unpredictable.8 An experienced Ayurvedic physician could classify his patients based on these types since the treatment modalities are individualistic and not based on controlled studies as in modern medicine. Each patient needs individual titration of the methods used for him. Since time-evolution, in a dynamic system, depends on the total initial state of the organism, controlled studies could be done using these personality types to match cohorts for better results in future. There are computerized systems to classify people based on this system.
Holistic Concept of Ayurveda:
Ayurveda does not look at the human body as a sum total of the organs. The physiology in Ayurveda takes into account every aspect of man’s existence, including the planetary influence. There is a whole science of Ayurvedic astrology. The various rhythms of the body like the circadian and ultradian were explained by their mode-locking to the most dominant rhythm of breathing. Breathing could control all the systems in the body except the one rhythm that occurs outside twenty-four hour cycle—the menstrual cycle which occurs once in twenty-eight days. This, Ayurveda, claimed is under the gravitational pull of the moon stimulating the human brain!
Kujendu hetu prathimaasaarthavam
(Because of the moon the woman menstruates once a month)
This might have looked very odd but for the fact that recent advances in human physiology have shown that the final stimulus for the endocrine orchestra that maintains the infradien rhythm of menstruation comes, from the gravitational effect of the moon on the cortical cells.9
Most of the present day ”so-called” Ayurvedic drugs in the market are reductionist in that they are only the extracts of the active principle in the plant to conform to the modern medical standards of drug sales. Dravyaguna, Ayurvedic pharmacodynamics, does not deal with active principles. It deals with the whole plant extract as envisaged in the ancient texts. This takes into effect even the photodynamicity of the plant. Some plants are to be harvested only after sunset lest their properties should change if harvested while the sun is up. Modern medicine now tells us that extracts might have serious side effects in the long run.10 Vitamin C in large doses, over long periods, could encourage cancer growth in the body, but eating tomato daily with lots of vitamin C in it, would not harm the body. There are many unknown chemicals in the whole plant that prevent the active ingredient from harming the patient while, at the same time, potentiating the good effects of the active principle. We will have to standardize the drug delivery methods to conform to the present standards but on the basis of holism only. In fact, herbal medicines are the least important part of Ayurvedic therapeutics. While yoga, panchakarma, and surgery are the mainstay, herbal medicines are occasionally used. Ayurvedic surgery was so advanced that the rhinoplasty method used by Ayurvedic physician, Shushruta, is being used by plastic surgeons even today. His anatomy classes lasted more than two years for students and he had devised most of the important emergency surgical methods.
What should an Ayurvedic doctor do?
His main job is to study his patient in great detail with special reference to his surroundings and classify him. Having done that he should then try and tailor the management strategies. Most of them would need panchakarma methods. Almost all of them would do well with change of mode of living that Ayurveda prescribes with special emphasis on diet, yoga, and exercise. Rarely do surgical methods and/or drugs become appropriate. With advances in modern science and technology, one cannot ignore the benefits of using modern hi-tech methods for emergency care. This requires the conventional Ayurvedic doctor to have a reasonably good knowledge of the modern medical methods to be able to give proper advice to patients. A judicious combination of modern medicine and Ayurveda would be an ideal training for a family doctor. More skilled specialists in either system could be used only at the referral point. This would bring down the top-heavy cost of modern medical care remarkably.
More than 80% of the illnesses are either minor or self-correcting. They could easily be helped using Ayurvedic methods and a placebo doctor. In addition, Ayurveda could help chronic debilitating diseases to a great extent, at a very small cost to the taxpayer. About 10% of the time modern medicine becomes mandatory. Roughly 90% of the unnecessary cost could be reduced for the benefit of all without detriment to public health. Rather, most of the iatrogenic problems could thus be avoided. Iatrogenesis is usually due to the long-term side effects of modern drugs. The latter form about 15% of hospital admissions. Modern medical doctors, who do not have an idea of Ayurveda and how it works, could be baffled when confronted with a patient who has probably taken the wrong advice from unscrupulous Ayurvedic practitioners. The whole gamut of these intricacies would have to be thrashed out before changing the system of medical education into a complementary holistic system.
Ayurveda would not be of much use in an emergency. For the management of emergencies we have to follow the modern medical methods. But for all the chronic degenerative and ageing problems Ayurveda is a panacea. The cost is very small in comparison. Modern medical drugs and interventions are good for acute emergencies, but in the long-run most of them have run into serious problems.
(Professor Dr BM Hegde, a Padma Bhushan awardee in 2010, is an MD, PhD, FRCP (London, Edinburgh, Glasgow & Dublin), FACC and FAMS. He is also the editor-in-chief of the Journal of the Science of Healing Outcomes, chairman of the State Health Society's Expert Committee, Govt of Bihar, Patna. He is former vice-chancellor of Manipal University at Mangalore and former professor for cardiology of the Middlesex Hospital Medical School, University of London. Prof Dr Hegde can be contacted at [email protected])
1) Strandberg TE, Salomaa VV, Naukkarinen VA, et. Al. Long-term mortality after 5-year multi-factorial primary prevention of cardiovascular diseases in middle aged men. JAMA 1991 Sep 4; 266(9): 1225-9.
2) Pimm vL, Ruud vW, Meyers V, & Elfeferich I. Near-death experience in survivors of cardiac arrest: a prospective study in Netherlands. Lancet 2001; 358: 2039-45.
3) Greyson B Dissociation in people who have near-death experiences: out of their bodies or out of their minds? Lancet 2000; 355: 460-63.
4) Sabom MB Light and death: one doctor’s fascinating account of near-death experience. Michigan: Zonderyan Publishing House, 1998: 37-52.
5) Bernardi et.al Effect of breathing rate on oxygen saturation and exercise performance in CHF. Lancet; 1997; 351:9112.
6) Hegde BM. Vaccination in India. J Assoc Physicians, India 1998; 47: 472-473.
7) Firth WJ. Chaos-predicting the unpredictable. BMJ 1991; 303; 1565-1569.
8) Cecil’s Textbook of Medicine 2001, page 1202.
9) Andersson OK, Almgren T, Persson B, et. al. Survival in treated hypertension: follow up study after two decades. BMJ 1998 Jul 18; 317(7152): 167-71.
10) McCormack J and Greenhalgh T Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study. BMJ 2000; 320:1720-3.
Nifty to move in the range of 4,600 and 4,735
The market opened in the green on the government’s initiative to attract more foreign funds. While intense volatility kept the benchmarks fluctuating in and out of the red for the entire session, brisk buying in the last hour helped the market end its four-session slide. Today the National Stock Exchange (NSE) traded on a low volume of 42.16 crore shares with too much of a downward bias, however, the Nifty ended in positive. The index has been able to cross its first support of 4,615. From here we may see the benchmark move sideways in the range of 4,600 and 4,735. But, if it breaks the lower range, the fall may go to the level of 4,455.
The market started the New Year on a buoyant note following the government’s announcement to allow qualified foreign investor (QFIs) to invest directly in the Indian stock market, a move which will help in attracting more foreign funds. The Nifty started the day at 4,640, a gain of 16 points, and the Sensex resumed trade 79 points up at 15,534. Auto, Consumer durables and metal stocks supported early gains. However, light selling after the positive open pushed the market into the red in less than an hour of the opening bell.
The indices were choppy in the absence of any cues from the Asian region where most markets were closed today. After hovering in and out of the red a couple of times, the benchmarks fell to the day’s lows. The Nifty hit 4,588 and the Sensex dropped to 15,358.
Aggressive short-covering in the last hour, once again, lifted the indices into the positive. The Sensex went on to hit its intraday high in late trade with the index at 15,543. The market finally managed to close higher, snapping its four-day decline. The Nifty added 12 points to close at 4,637 and the Sensex settled at 15,518, a rise of 63 points.
The advance-decline ratio on the NSE was 881:826.
The broader indices settled mixed in today’s trade. The BSE Mid-cap index lost 0.07% while the BSE Small-cap index added 0.11%.
The top sectoral gainers were BSE Consumer Durables (up 1.35%); Oil & Gas (up 1.31%); BSE IT (up 1.23%); BSE TECk (up 1.08%) and BSE Metal (up 0.64%). The top declining sectors were BSE Fast Moving Consumer Goods (up 1.31%); BSE Auto (down 1.20%); BSE Power (down 0.44%); BSE Realty (down 0.39%) and BSE Healthcare (down 0.16%).
Coal India (up 3.61%); Tata Motors (up 3.03%); Reliance Industries (up 2.03%); Maruti Suzuki (up 1.82%) and ICICI Bank (up 1.73%) were the main gainers on the Sensex. The laggards were led by Bajaj Auto (down 7.40%); Hero MotoCorp (down 3.50%); Hindalco Industries (down 3.02%); DLF (down 2.13%) and NTPC (down 1.53%).
The Nifty toppers were Coal India (up 4.11%); Tata Motors (up 3.47%); Reliance Communications (up 3.35%); Maruti Suzuki (up 2.15%) and Tata Steel (up 2.12%). The draggers of the index were Bajaj Auto (down 7.86%); Sesa Goa (down 4.53%); Hero MotoCorp (down 3.62%); Hindalco Ind (down 2.89%) and Grasim (down 2.84%).
Most markets in Asia were closed for trade today for the New Year’s holiday. In economic news from the region, South Korea’s manufacturing activity for December dropped to a three-year low on the back of concerns about the global slowdown.
Among those that were open, the Seoul Composite closed 0.03% up while the Jakarta Composite fell 0.34% and the Taiwan Weighted tumbled 1.69%. At the time of writing, key European markets were in the positive. The US market will remain closed on Monday.
Back home, foreign institutional investors were net sellers of shares totalling Rs178.15 crore on Friday. On the other hand, domestic institutional investors were net buyers of stocks worth Rs266.60 crore.
SUV major Mahindra & Mahindra’s Farm Equipment Sector (FES) division today reported a marginal increase in tractor sales in December 2011, at 16,389 units compared to 16,334 units during the same month the previous year.
Domestic sales were up 1.19% to 15,315 units while exports during the month dipped 10.43% to 1,074 units. The stock declined 1.18% to close at Rs673.75 on the NSE.
Indiabulls Real Estate plans to buyback its fully paid-up equity shares of face value Rs2 each from existing shareholders at a price of Rs75 per share with the buyback size not exceeding Rs450 crore. The company plans to buy back 6 crore shares, which would sum up to approximately 12.66% of the pre buyback equity shares of the company. The stock rose 0.86% to close at Rs47.15 on the NSE.
Surya Roshni, the second-largest lighting company in the country, is setting up a light-emitting diode (LED) bulb laboratory and research centre in Uttarakhand at a cost of Rs15 crore with a view to give a boost to the segment. The Surya Group is eyeing a turnover of Rs5,000 crore next fiscal, up from the present Rs3,000 crore. The stock surged 1.15% to close at Rs43.90 on the NSE.